Stocks
Aeterna Zentaris Inc.AEZS
NASDAQHealthcareBiotechnology$5.72+2.14%
A development-stage biopharmaceutical company focused on therapies and diagnostics in endocrinology and oncology. Its primary asset historically has been macimorelin, an oral diagnostic test for adult growth hormone deficiency that has been licensed to commercial partners in several markets. With a ...
Market Cap: $17.5M52W Range: $0.15 – $9.32
Congressional Interest in Aeterna Zentaris Inc. (AEZS)
1 member of Congress has disclosed 2 trades in Aeterna Zentaris Inc. (AEZS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading AEZS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-20 | Roger W. Marshall | sell | $1K – $15K |
| 2017-07-19 | Roger W. Marshall | buy | $1K – $15K |